Clinical Trials Browser

Phase 2/3 × Nasopharyngeal Carcinoma × camrelizumab × Clear all

NCT05576272 2023-11-22

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma